LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

Phibro Animal Health Corp

Geschlossen

BrancheGesundheitswesen

51.23 -0.37

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

50.7

Max

52.13

Schlüsselkennzahlen

By Trading Economics

Einkommen

932K

27M

Verkäufe

10M

374M

KGV

Branchendurchschnitt

23.462

121.746

EPS

0.87

Dividendenrendite

0.9

Gewinnspanne

7.344

Angestellte

2,475

EBITDA

-12M

50M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

-6.79% downside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.90%

2.26%

Nächstes Ergebnis

6. Mai 2026

Nächste Dividendenausschüttung

25. März 2026

Nächstes Ex-Dividendendatum

4. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

403M

2.1B

Vorheriger Eröffnungskurs

51.6

Vorheriger Schlusskurs

51.23

Nachrichtenstimmung

By Acuity

45%

55%

138 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Phibro Animal Health Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Feb. 2026, 23:47 UTC

Heiße Aktien

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11. Feb. 2026, 22:59 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Grab Holdings to Buy U.S.-Based Stash Financial

11. Feb. 2026, 23:54 UTC

Ergebnisse

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11. Feb. 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

11. Feb. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11. Feb. 2026, 23:49 UTC

Ergebnisse

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11. Feb. 2026, 23:45 UTC

Ergebnisse

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11. Feb. 2026, 23:42 UTC

Ergebnisse

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11. Feb. 2026, 23:41 UTC

Ergebnisse

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11. Feb. 2026, 23:40 UTC

Ergebnisse

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11. Feb. 2026, 23:35 UTC

Market Talk

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11. Feb. 2026, 23:18 UTC

Market Talk

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11. Feb. 2026, 23:14 UTC

Market Talk

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11. Feb. 2026, 22:58 UTC

Ergebnisse

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11. Feb. 2026, 22:57 UTC

Ergebnisse

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11. Feb. 2026, 22:54 UTC

Ergebnisse

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11. Feb. 2026, 22:53 UTC

Ergebnisse

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11. Feb. 2026, 22:47 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11. Feb. 2026, 22:47 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11. Feb. 2026, 22:23 UTC

Ergebnisse

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11. Feb. 2026, 22:22 UTC

Ergebnisse

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11. Feb. 2026, 22:22 UTC

Ergebnisse

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11. Feb. 2026, 22:19 UTC

Ergebnisse

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11. Feb. 2026, 22:16 UTC

Ergebnisse

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Peer-Vergleich

Kursveränderung

Phibro Animal Health Corp Prognose

Kursziel

By TipRanks

-6.79% Nachteil

12-Monats-Prognose

Durchschnitt 48.33 USD  -6.79%

Hoch 58 USD

Tief 38 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Phibro Animal Health Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

3 ratings

1

Buy

1

Halten

1

Sell

Technischer Score

By Trading Central

17 / N/AUnterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

138 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
help-icon Live chat